Compugen publishes corporate presentation on AI-driven immuno-oncology antibody pipelinePUBT·12 hours agoCGEN+1.28%GILD+0.72%
Compugen Q2 FY26 net loss narrows to USD 7 million; revenue more than doubled to USD 2.6 millionPUBT·12 hours agoCGEN+1.28%GILD+0.72%
Compugen Reports Second Quarter 2026 Results | CGEN Stock NewsStockTitan·20 hours agoCGEN+1.28%AZN-6.88%
Compugen SVP Business Development Zurit Levine disposes of 1,875 common shares worth $4,687.5PUBT·Jul 13 at 03:02 PMCGEN+1.28%
Market Orphans or Hidden Gems? Why These 9 Stocks Are Lumped Together in 2026Global Report·Jul 9 at 09:03 PMSGP+0.67%FRGT+10.54%
Cross-Sector Rotation: AI Monetization Accelerates as Biotech and ADRs Hit Key MilestonesGlobal Report·Jul 9 at 05:03 AMMNSO-1.15%ORKA-1.78%
Markets Weigh Cross-Sector Fundamentals for Signals on the Next Economic PhaseGlobal Report·Jul 8 at 10:32 PMNEXA0.00%PCRHY+0.63%
Compugen presents MAIA-ovarian platform trial poster for COM701 maintenance in relapsed platinum-sensitive ovarian cancer at ESMO congressPUBT·Jun 18 at 06:01 AMCGEN+1.28%
Compugen Q1 2026 Earnings Call: Complete Transcriptbenzinga_article·Jun 1 at 08:04 AMCGEN+1.28%AZN-6.88%
